TickerFacts.

Company research / ZTS

Zoetis Inc. (ZTS)

Build a valuation ↗↓ Download CSV

CIK 0001555280 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Zoetis Inc. reported revenue of $9.47B. Revenue grew 2.3% from the prior annual period.

Key ratios (year ended 2025-12-31)

71.8%
Gross margin (computed)
28.2%
Net margin
80.2%
Return on year-end equity
2.3%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-13

Headquarters locality: Florham Park · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$9.47B$9.26B$8.54B$8.08B$7.78B$6.67B$6.26B$5.83B$5.31B$4.89B
Cost of Revenue$2.67B$2.72B$2.56B$2.45B$2.30B$2.06B$1.99B$1.91B$1.77B$1.67B
Gross Profit (computed)$6.80B$6.54B$5.98B$5.63B$5.47B$4.62B$4.27B$3.91B$3.53B$3.22B
R&D Expense$698.00M$686.00M$614.00M$539.00M$508.00M$463.00M$457.00M$432.00M$382.00M$376.00M
Depreciation & Amortization$487.00M$497.00M$491.00M$465.00M$448.00M$441.00M$412.00M$308.00M$242.00M$240.00M
Net Income$2.67B$2.49B$2.34B$2.11B$2.04B$1.64B$1.50B$1.43B$864.00M$821.00M
EPS (Diluted)$6.02$5.47$5.07$4.49$4.27$3.42$3.11$2.93$1.75$1.65
Total Assets$15.47B$14.24B$14.29B$14.93B$13.90B$13.61B$11.54B$10.78B$8.59B$7.65B
Total Liabilities$12.14B$9.47B$9.29B$10.52B$9.36B$9.84B$8.84B$8.59B$6.80B$6.15B
Shareholders' Equity$3.33B$4.77B$4.99B$4.40B$4.54B$3.77B$2.71B$2.19B$1.79B$1.50B
Cash & Equivalentsn/an/an/an/an/an/an/an/a$1.56B$727.00M
Operating Cash Flow$2.90B$2.95B$2.35B$1.91B$2.21B$2.13B$1.79B$1.79B$1.35B$713.00M
Capital Expenditures$621.00M$655.00M$732.00M$586.00M$477.00M$453.00M$460.00M$338.00M$224.00M$216.00M
Free Cash Flow$2.28B$2.30B$1.62B$1.33B$1.74B$1.67B$1.33B$1.45B$1.12B$497.00M
Share Repurchases$3.23B$1.86B$1.09B$1.59B$743.00M$250.00M$626.00M$698.00M$500.00M$300.00M
Shares Outstanding424.93M448.47M458.37M463.81M472.57M475.32M475.53M479.56M486.13M492.86M
Dividends Per Share$2.03$1.80$1.56$1.35$1.07$0.85$0.69$0.54$0.44$0.39
Weighted Average Diluted Shares443.83M454.85M462.27M470.38M476.72M478.57M481.79M486.90M493.16M498.23M
EPS (Basic)$6.03$5.47$5.08$4.51$4.29$3.44$3.14$2.96$1.76$1.66

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView